306 related articles for article (PubMed ID: 28918125)
1. Iodinated chlorin p
Sarbadhikary P; Dube A
Chem Biol Interact; 2017 Nov; 277():137-144. PubMed ID: 28918125
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiosensitivity of oral carcinoma cells by iodinated chlorin p
Sarbadhikary P; Dube A
J Synchrotron Radiat; 2017 Nov; 24(Pt 6):1265-1275. PubMed ID: 29091070
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic investigations on the binding of an iodinated chlorin p
Sarbadhikary P; Dube A
Photochem Photobiol Sci; 2017 Dec; 16(12):1762-1770. PubMed ID: 29087425
[TBL] [Abstract][Full Text] [Related]
4. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
6. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
Andrade Volkart P; Benedetti Gassen R; Mühlen Nogueira B; Nery Porto B; Eduardo Vargas J; Arigony Souto A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3238-3242. PubMed ID: 28647350
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes.
Kordestani N; Rudbari HA; Fernandes AR; Raposo LR; Baptista PV; Ferreira D; Bruno G; Bella G; Scopelliti R; Braun JD; Herbert DE; Blacque O
ACS Comb Sci; 2020 Feb; 22(2):89-99. PubMed ID: 31913012
[TBL] [Abstract][Full Text] [Related]
10. Cu
Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxicity effects of a novel Cu complex on MCF-7 human breast cancerous cells.
Mohammadizadeh F; Falahati-Pour SK; Rezaei A; Mohamadi M; Hajizadeh MR; Mirzaei MR; Khoshdel A; Fahmidehkar MA; Mahmoodi M
Biometals; 2018 Apr; 31(2):233-242. PubMed ID: 29429042
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines.
Dhivya R; Jaividhya P; Riyasdeen A; Palaniandavar M; Mathan G; Akbarsha MA
Biometals; 2015 Oct; 28(5):929-43. PubMed ID: 26335033
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
15. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
Qi J; Yao Q; Tian L; Wang Y
Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
[TBL] [Abstract][Full Text] [Related]
17. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
Liu M; Song XQ; Wu YD; Qian J; Xu JY
Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
[TBL] [Abstract][Full Text] [Related]
18. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization.
Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR
J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599
[TBL] [Abstract][Full Text] [Related]
19. Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects.
Vančo J; Trávníček Z; Hošek J; Malina T; Dvořák Z
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299247
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
